These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11062372)

  • 21. Results of high intensity focused ultrasound treatment of prostate cancer: early Canadian experience at a single center.
    Elterman DS; Barkin J; Radomski SB; Fleshner NE; Liu B; Bensimon K; Arora S; Robinette M; Finelli A
    Can J Urol; 2011 Dec; 18(6):6037-42. PubMed ID: 22166332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transrectal high-intensity focused ultrasound in the treatment of localized prostate cancer: a multicenter study.
    Uchida T; Baba S; Irie A; Soh S; Masumori N; Tsukamoto T; Nakatsu H; Fujimoto H; Kakizoe T; Ueda T; Ichikawa T; Ohta N; Kitamura T; Sumitomo M; Hayakawa M; Aoyagi T; Tachibana M; Ikeda R; Suzuki K; Tsuru N; Suzuki K; Ozono S; Fujimoto K; Hirao Y; Monden K; Nasu Y; Kumon H; Nishi K; Ueda S; Koga H; Naitoh S
    Hinyokika Kiyo; 2005 Oct; 51(10):651-8. PubMed ID: 16285617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-intensity focused ultrasound: complications and adverse events.
    Thüroff S; Chaussy C
    Mol Urol; 2000; 4(3):183-7;discussion 189. PubMed ID: 11062373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [High intensity focused ultrasound in localized prostate cancer].
    Coulange C
    Cancer Radiother; 2005 Nov; 9(6-7):377-8. PubMed ID: 16168696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapy of local prostatic carcinoma with high intensity focussed ultrasound (HIFU). Outcome and side-effects].
    Thüroff S; Chaussy C
    Urologe A; 2001 May; 40(3):191-4. PubMed ID: 11405127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer.
    Blana A; Murat FJ; Walter B; Thuroff S; Wieland WF; Chaussy C; Gelet A
    Eur Urol; 2008 Jun; 53(6):1194-201. PubMed ID: 17997026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New treatments for localized prostate cancer.
    Marberger M; Carroll PR; Zelefsky MJ; Coleman JA; Hricak H; Scardino PT; Abenhaim LL
    Urology; 2008 Dec; 72(6 Suppl):S36-43. PubMed ID: 19095127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Location of residual cancer after transrectal high-intensity focused ultrasound ablation for clinically localized prostate cancer.
    Boutier R; Girouin N; Cheikh AB; Belot A; Rabilloud M; Gelet A; Chapelon JY; Rouvière O
    BJU Int; 2011 Dec; 108(11):1776-81. PubMed ID: 21711432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transrectal high-intensity focused ultrasound for treatment for patients with biochemical failure after radical prostatectomy.
    Hayashi M; Shinmei S; Asano K
    Int J Urol; 2007 Nov; 14(11):1048-50. PubMed ID: 17956536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of color Doppler in guiding prostate biopsy after HIFU ablation.
    Rouvière O; Mège-Lechevallier F; Chapelon JY; Gelet A; Bouvier R; Boutitie F; Lyonnet D
    Eur Urol; 2006 Sep; 50(3):490-7. PubMed ID: 16439055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-intensity focused ultrasound (HIFU) for definitive treatment of prostate cancer.
    Cordeiro ER; Cathelineau X; Thüroff S; Marberger M; Crouzet S; de la Rosette JJ
    BJU Int; 2012 Nov; 110(9):1228-42. PubMed ID: 22672199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Locally recurrent prostatic adenocarcinoma after exclusive radiotherapy: results of high intensity focused ultrasound].
    Poissonnier L; Murat FJ; Belot A; Bouvier R; Rabilloud M; Rouviere O; Chapelon JY; Gelet A
    Prog Urol; 2008 Apr; 18(4):223-9. PubMed ID: 18501302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
    Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of high-intensity focused ultrasound on human prostate cancer in vivo.
    Madersbacher S; Pedevilla M; Vingers L; Susani M; Marberger M
    Cancer Res; 1995 Aug; 55(15):3346-51. PubMed ID: 7542168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results.
    Demanes DJ; Rodriguez RR; Schour L; Brandt D; Altieri G
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1306-16. PubMed ID: 15817332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [High intensity focused ultrasound combined with endocrine therapy in treating prostate cancer].
    Hua LX; Wu HF; Sui YG; Zhang W; Qian LX; Song NH; Zhang JX
    Zhonghua Nan Ke Xue; 2005 Mar; 11(3):195-7. PubMed ID: 15804111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salvage laparoscopic extraperitoneal radical prostatectomy after failed high-intensity focused ultrasound and radiotherapy for localized prostate cancer.
    Stolzenburg JU; Bynens B; Do M; Rabenalt R; Katsakiori PF; Liatsikos E
    Urology; 2007 Nov; 70(5):956-60. PubMed ID: 17919699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histopathological findings after treatment of prostate cancer using high-intensity focused ultrasound (HIFU).
    Biermann K; Montironi R; Lopez-Beltran A; Zhang S; Cheng L
    Prostate; 2010 Aug; 70(11):1196-200. PubMed ID: 20564422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extracorporeal application of high-intensity focused ultrasound for prostatic tissue ablation.
    Häcker A; Köhrmann KU; Back W; Kraut O; Marlinghaus E; Alken P; Michel MS
    BJU Int; 2005 Jul; 96(1):71-6. PubMed ID: 15963124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of neoadjuvant androgen suppression on prostate cancer-related outcomes after high-intensity focused ultrasound therapy.
    Uchida T; Illing RO; Cathcart PJ; Emberton M
    BJU Int; 2006 Oct; 98(4):770-2. PubMed ID: 16879448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.